je.st
news
Drugmaker Lilly's 2016 forecast misses Street expectations
2016-01-05 15:04:53| Biotech - Topix.net
The drugmaker says it expects adjusted earnings in the new year to range between $3.45 and $3.55 per share, excluding charges like deal integration costs. It predicts revenue of between $20.2 billion and $20.7 billion.
Tags: street
expectations
forecast
misses
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||